-Reuters
Reported Late Wednesday, Aura Biosciences Announces Pricing Of $80.4M Public Offering Of 6.7M Shares Of Common Stock At A Price Of $12/Share
Aura Biosciences, Inc. ("Aura") (NASDAQ:AURA), a clinical-stage biotechnology company developing a novel class of virus-like drug conjugate (VDC) therapies for multiple oncology indications, today announced the